These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17978532)

  • 1. Thalamic hyperperfusion in verbal hallucination of Parkinsonian patients.
    Matsui H; Nishinaka K; Miyoshi T; Hara N; Oda M; Kubori T; Udaka F
    Intern Med; 2007; 46(21):1765-9. PubMed ID: 17978532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.
    Matsui H; Nishinaka K; Oda M; Hara N; Komatsu K; Kubori T; Udaka F
    Mov Disord; 2006 Dec; 21(12):2165-9. PubMed ID: 17029260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features.
    Matsui H; Udaka F; Miyoshi T; Hara N; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    Parkinsonism Relat Disord; 2005 Jun; 11(4):227-32. PubMed ID: 15878583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-induced hallucination and cerebral blood flow in Parkinson's disease.
    Okada K; Suyama N; Oguro H; Yamaguchi S; Kobayashi S
    J Neurol; 1999 May; 246(5):365-8. PubMed ID: 10399867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucination in Parkinson's disease with FDG PET.
    Nagano-Saito A; Washimi Y; Arahata Y; Iwai K; Kawatsu S; Ito K; Nakamura A; Abe Y; Yamada T; Kato T; Kachi T
    Mov Disord; 2004 Jul; 19(7):801-806. PubMed ID: 15254938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functions in Parkinson's disease: relation to disease severity and hallucination.
    Wakamori T; Agari T; Yasuhara T; Kameda M; Kondo A; Shinko A; Sasada S; Sasaki T; Furuta T; Date I
    Parkinsonism Relat Disord; 2014 Apr; 20(4):415-20. PubMed ID: 24467818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations.
    Oishi N; Udaka F; Kameyama M; Sawamoto N; Hashikawa K; Fukuyama H
    Neurology; 2005 Dec; 65(11):1708-15. PubMed ID: 16344511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of successful treatment with donepezil of olfactory hallucination in parkinson disease].
    Osada O; Iwasaki A
    Rinsho Shinkeigaku; 2017 Jan; 57(1):29-32. PubMed ID: 27980286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Tashiro K; Kikuchi S; Sasaki H
    J Neurol Sci; 2006 Feb; 241(1-2):67-72. PubMed ID: 16352310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson's disease.
    Matsui H; Udaka F; Miyoshi T; Hara N; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    Acta Neurol Scand; 2005 Jul; 112(1):36-41. PubMed ID: 15932354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia.
    Osaki Y; Morita Y; Fukumoto M; Akagi N; Yoshida S; Doi Y
    Mov Disord; 2005 Aug; 20(8):999-1005. PubMed ID: 15806567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.
    Goetz CG; Stebbins GT; Ouyang B
    Mov Disord; 2011 Oct; 26(12):2196-200. PubMed ID: 21755536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain perfusion alterations in depressed patients with Parkinson's disease.
    Kim YD; Jeong HS; Song IU; Chung YA; Namgung E; Kim YD
    Ann Nucl Med; 2016 Dec; 30(10):731-737. PubMed ID: 27566684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT].
    Sakai T; Kuzuhara S
    No To Shinkei; 2006 Jan; 58(1):29-37. PubMed ID: 16482919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperperfusion in primary somatosensory region related to somatic hallucination in the elderly.
    Nemoto K; Mizukami K; Hori T; Tachikawa H; Ota M; Takeda T; Ohnishi T; Matsuda H; Asada T
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):421-5. PubMed ID: 20492558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-isopropyl-p- 123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia.
    Matsui H; Udaka F; Miyoshi T; Hara N; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    Intern Med; 2005 Oct; 44(10):1046-50. PubMed ID: 16293914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease.
    Imon Y; Matsuda H; Ogawa M; Kogure D; Sunohara N
    J Nucl Med; 1999 Oct; 40(10):1583-9. PubMed ID: 10520695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.